CIP2A Constrains Th17 Differentiation by Modulating STAT3 Signaling

Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A) is an oncogene and a potential cancer therapy target protein. Accordingly, a better understanding of the physiological function of CIP2A, especially in the context of immune cells, is a prerequisite for its exploitation in cancer therapy. Here, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Mohd Moin, Ullah, Ubaid, Khan, Meraj H., Kong, Lingjia, Moulder, Robert, Välikangas, Tommi, Bhosale, Santosh Dilip, Komsi, Elina, Rasool, Omid, Chen, Zhi, Elo, Laura L., Westermarck, Jukka, Lahesmaa, Riitta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068643/
https://www.ncbi.nlm.nih.gov/pubmed/32171124
http://dx.doi.org/10.1016/j.isci.2020.100947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068643/
https://www.ncbi.nlm.nih.gov/pubmed/32171124
http://dx.doi.org/10.1016/j.isci.2020.100947

Ejemplares similares